05/27/2015 - 10:57am

Ahold's U.S. private-label penetration reached 37.7% for first quarter 2015. 

05/26/2015 - 4:46pm

Appeals court forces Actavis to keep its Alzheimer's treatment Namenda IR on the market. 

05/26/2015 - 4:07pm

Acquisition target Perrigo recently filed a complaint to Irish Takeover Panel regarding Mylan proposal. 

05/26/2015 - 3:40pm

Specialized manufacturers are gearing up for a robust trade out of generic biosimilar approvals, Kalorama reported last week. 

05/26/2015 - 3:23pm

Aurobindo Pharma has submitted an abbreviated new drug application for dolutegravir 50 mg to the Food and Drug Administration for the treatment of HIV.

05/26/2015 - 3:09pm

The 21st Century Cures legislation would foster drug development. 

05/26/2015 - 3:08pm

The Food and Drug Administration has approved Boehringer Ingelheim, Inc.'s Stiolto Respimat (tiotropium bromide and olodaterol), a once-daily inhaler meant to treat obstructed airflow in patients, the company announced Tuesday. 

05/26/2015 - 2:55pm

Former Walmart EVP and chief merchandising officer Duncan Mac Naughton has joined the board of directors of Crossmark, a sales, marketing and merchandising services company focused on the retail and consumer goods industries.

05/26/2015 - 2:00pm

Bartell Drugs isn’t just celebrating its 125th anniversary. The regional player is also celebrating the deployment of its own private-label brand, which is designed to highlight the retailer’s connection to the Puget Sound region, The Seattle Times has reported.